These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7479562)

  • 1. Quantitative microdialysis for studying the in vivo L-DOPA kinetics in blood and skeletal muscle of the dog.
    Sarre S; Deleu D; Van Belle K; Ebinger G; Michotte Y
    Pharm Res; 1995 May; 12(5):746-50. PubMed ID: 7479562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of carbidopa on the pharmacokinetics and metabolism of intravenously administered levodopa in blood plasma and skeletal muscle.
    Deleu D; Sarre S; Ebinger G; Michotte Y
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):576-81. PubMed ID: 8133901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of carbidopa and entacapone pretreatment on the L-dopa pharmacokinetics and metabolism in blood plasma and skeletal muscle in beagle dog: an in vivo microdialysis study.
    Deleu D; Sarre S; Ebinger G; Michotte Y
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1323-31. PubMed ID: 7791104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous monitoring of levodopa, dopamine and their metabolites in skeletal muscle and subcutaneous tissue in different pharmacological conditions using microdialysis.
    Deleu D; Sarre S; Ebinger G; Michotte Y
    J Pharm Biomed Anal; 1993 Jul; 11(7):577-85. PubMed ID: 8399532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo pharmacokinetics of levodopa and 3-O-methyldopa in muscle. A microdialysis study.
    Deleu D; Sarre S; Ebinger G; Michotte Y
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Nov; 344(5):514-9. PubMed ID: 1811168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous in vivo microdialysis in plasma and skeletal muscle: a study of the pharmacokinetic properties of levodopa by noncompartmental analysis.
    Deleu D; Sarre S; Michotte Y; Ebinger G
    J Pharm Sci; 1994 Jan; 83(1):25-8. PubMed ID: 8138904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous intravenous monitoring of levodopa and 3-O-methyldopa by microdialysis and high-performance liquid chromatography with electrochemical detection.
    Deleu D; Sarre S; Herregodts P; Ebinger G; Michotte Y
    J Pharm Biomed Anal; 1991; 9(2):159-65. PubMed ID: 1873307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified high-performance liquid chromatography with electrochemical detection method for plasma measurement of levodopa, 3-O-methyldopa, dopamine, carbidopa and 3,4-dihydroxyphenyl acetic acid.
    Karimi M; Carl JL; Loftin S; Perlmutter JS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 836(1-2):120-3. PubMed ID: 16584928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats.
    Rose S; Jenner P; Marsden CD
    Mov Disord; 1988; 3(2):117-25. PubMed ID: 3221899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian phase dependent pharmacokinetics of L-dopa, its main metabolites (3-OMD, HVA, DOPAC) and carbidopa in rats.
    Andre MH; Grignon S; Bruguerolle B
    Fundam Clin Pharmacol; 1996; 10(4):350-5. PubMed ID: 8871134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of dopamine and its metabolites in the intracellular and extracellular compartments of the rat striatum after peripheral administration of L-[11C]dopa.
    Miwa S; Gillberg PG; Bjurling P; Yumoto N; Odano I; Watanabe Y; Långström B
    Brain Res; 1992 Apr; 578(1-2):122-8. PubMed ID: 1511268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vivo comparison of the capacity of striatal versus extrastriatal brain regions to form dopamine from exogenously administered L-dopa.
    Brannan T; Prikhojan A; Yahr MD
    J Neural Transm (Vienna); 1996; 103(11):1287-94. PubMed ID: 9013415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral pharmacokinetic handling and metabolism of L-dopa in the rat: the effect of route of administration and carbidopa pretreatment.
    Rose S; Jenner P; Marsden CD
    J Pharm Pharmacol; 1991 May; 43(5):325-30. PubMed ID: 1680174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of levodopa and 3-O-methyldopa in human plasma by liquid chromatography with electrochemical detection.
    Saxer C; Niina M; Nakashima A; Nagae Y; Masuda N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 802(2):299-305. PubMed ID: 15018791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeic acid improves the bioavailability of L-dopa in rabbit plasma.
    Wang LH; Hsu KY; Uang YS; Hsu FL; Yang LM; Lin SJ
    Phytother Res; 2010 Jun; 24(6):852-8. PubMed ID: 19941381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study.
    Sarre S; Herregodts P; Deleu D; Devrieze A; De Klippel N; Ebinger G; Michotte Y
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):277-85. PubMed ID: 1407014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 3-O-methyldopa, L-3,4-dihydroxyphenylalanine metabolite, on locomotor activity and dopamine turnover in rats.
    Onzawa Y; Kimura Y; Uzuhashi K; Shirasuna M; Hirosawa T; Taogoshi T; Kihira K
    Biol Pharm Bull; 2012; 35(8):1244-8. PubMed ID: 22863920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
    Parada A; Loureiro AI; Vieira-Coelho MA; Hainzl D; Soares-da-Silva P
    Eur J Pharmacol; 2001 May; 420(1):27-32. PubMed ID: 11412836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
    Waldmeier PC; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):133-40. PubMed ID: 1012333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.